Skip to main content
  • Imaging
      |Imaging
    • Cardiac
    • Clinical Research
    • COVID
    • Interventional
    • Molecular
    • Neuro
    • Nuclear
    • Oncology
    • Orthopedic
    • Radiation Oncology
    • Screening
    • Women's
  • Technology
      |Technology
    • Artificial Intelligence
    • Contrast
    • CT
    • Enterprise Imaging
    • Imaging Informatics
    • Informatics
    • MRI
    • PACS
    • PET/CT
    • Ultrasound
    • X-Ray
  • Management
      |Management
    • Education & Training
    • Leadership
    • Patient Care
    • Policy & Regulations
    • Practice Management
    • Professional Associations
    • Quality
    • Staffing
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHRA
    • ACR
    • ARRS
    • ASRT
    • RBMA
    • RSNA
    • SBI
    • SCCT
    • SIIM
    • SIR
    • SNMMI
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe

Search form

Home

Why RadNet is betting heavily on AI to reshape radiology workflows

Howard Berger, MD, RadNet chairman and CEO, discusses why the company has invested millions into DeepHealth to rapidly build up a new business model for artificial intelligence capabilities in radiology. #RSNA #HealthAI #ClinicalAI #Radiology

RadNet Chaiman and CEO Howard Berger, MD, explains why the company has invested tens of millions into DeepHealth to rapidly build up a new business model. 

 

  • Read more about Why RadNet is betting heavily on AI to reshape radiology workflows

PHOTO GALLERY: What does acute COVID-19 and long COVID look like on medical imaging?

COVID-19 medical imaging examples of various clinical presentations. SARS-CoV-2 clinical imaging presentations.

This image gallery shows what the various clinical presentations associated with the COVID-19 and long COVID that have been documented during and after coronavirus pandemic.

  • Read more about PHOTO GALLERY: What does acute COVID-19 and long COVID look like on medical imaging?

$64M raised for new cardiogenic shock drug—research already underway

Illustration showing how procizumab captures circulating dipeptidyl peptidase 3 (cDPP3) to block this key molecular driver of shock. Illustrations courtesy of 4TEEN4

Illustration showing how procizumab captures circulating dipeptidyl peptidase 3 (cDPP3) to block this key molecular driver of cardiogenic shock. Illustration courtesy of 4TEEN4 
 

Procizumab was developed to change the trajectory of shock by addressing an underlying molecular driver rather than just managing symptoms.

  • Read more about $64M raised for new cardiogenic shock drug—research already underway

Republicans win shutdown showdown—Senate agrees to funding deal without ACA subsidy extension

Congress Senate Washington D.C. DC

With eight Democrats agreeing to the Republican-backed deal that reverses the firings of federal workers, the Senate now has the 60 votes needed for the bill to advance. The rehirings will include the 1,200 workers fired at the Department of Health and Human Services. 

  • Read more about Republicans win shutdown showdown—Senate agrees to funding deal without ACA subsidy extension

Study highlights CT findings that could mask lung cancer, leading to delayed diagnosis

lung cancer screening

For many patients with interstitial lung disease, cancer could go undetected for years, putting them at risk of disease progression that would require more extensive treatment.

  • Read more about Study highlights CT findings that could mask lung cancer, leading to delayed diagnosis

Machine learning model predicts which radiotherapy patients are most vulnerable to adverse side effects

maya kowalski case

The model integrates structured EHR data spanning patient characteristics, cancer treatment, vitals, lab results, medications and prior acute care utilization to determine an individual’s risk of requiring urgent care throughout the course of their treatment.

  • Read more about Machine learning model predicts which radiotherapy patients are most vulnerable to adverse side effects

AI turns mammograms into CVD risk assessments—no outside data required

mammogram mammography breast cancer

Thanks to AI, clinicians can use mammograms to do a lot more than identify signs of breast cancer. Researchers explored data from nearly 50,000 patients, presenting their findings in Heart.

  • Read more about AI turns mammograms into CVD risk assessments—no outside data required

Fewer than 30% of FDA-cleared AI devices share key safety, adverse event info prior to approval

A new analysis is prompting questions regarding how rigorously many of the AI-enabled tools approved by the U.S. Food and Drug Administration are evaluated prior to their clearance. 

  • Read more about Fewer than 30% of FDA-cleared AI devices share key safety, adverse event info prior to approval

Does BMI affect AI's accuracy when assessing CT scans?

Obesity Paradox Body Mass Index

Photo by Kenny Eliason via Unsplash

AI is only as effective as the data it was trained on, and many datasets lack diversity in terms of patient body mass index.

  • Read more about Does BMI affect AI's accuracy when assessing CT scans?

New GE HealthCare partnership expands access to prostate cancer imaging agent

Prostate Blue Ribbon

The product, which is used to detect metastatic or recurrent prostate cancer, was approved by the FDA in 2021. 

  • Read more about New GE HealthCare partnership expands access to prostate cancer imaging agent

Pagination

    • Current page 1
    • Page 2
    • Page 3
    • Page 4
    • Page 5
    • Page 6
    • Page 7
    • Page 8
    • Page 9 …
    • Next page Next ›
    • Last page Last »
Subscribe
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme